HomeCompareQGLHF vs ABBV

QGLHF vs ABBV: Dividend Comparison 2026

QGLHF yields 1818.18% · ABBV yields 3.06%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QGLHF wins by $9.54M in total portfolio value
10 years
QGLHF
QGLHF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.64M
Annual income
$86,245.75
Full QGLHF calculator →
ABBV
AbbVie Inc.
● Live price
3.06%
Share price
$217.44
Annual div
$6.65
5Y div CAGR
40.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$102.3K
Annual income
$24,771.77
Full ABBV calculator →

Portfolio growth — QGLHF vs ABBV

📍 QGLHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQGLHFABBV
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QGLHF + ABBV cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QGLHF pays
ABBV pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QGLHF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$73,308.89/yr
ABBV
Annual income on $10K today (after 15% tax)
$259.96/yr
After 10yr DRIP, annual income (after tax)
$21,056.00/yr
At 15% tax rate, QGLHF beats the other by $52,252.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QGLHF + ABBV for your $10,000?

QGLHF: 50%ABBV: 50%
100% ABBV50/50100% QGLHF
Portfolio after 10yr
$4.87M
Annual income
$55,508.76/yr
Blended yield
1.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ABBV right now

QGLHF
No analyst data
Altman Z
1.9
Piotroski
5/9
ABBV
Analyst Ratings
27
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$256.15
+17.8% upside vs current
Range: $223.00 — $299.00
Altman Z
2.0
Piotroski
8/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QGLHF buys
0
ABBV buys
0
No recent congressional trades found for QGLHF or ABBV in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQGLHFABBV
Forward yield1818.18%3.06%
Annual dividend / share$2.00$6.65
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%40.6%
Portfolio after 10y$9.64M$102.3K
Annual income after 10y$86,245.75$24,771.77
Total dividends collected$6.74M$61.0K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: QGLHF vs ABBV ($10,000, DRIP)

YearQGLHF PortfolioQGLHF Income/yrABBV PortfolioABBV Income/yrGap
1← crossover$101,609$90,909.09$11,550$430.00+$90.1KQGLHF
2$540,366$431,644.40$13,472$627.96+$526.9KQGLHF
3$1,650,866$1,072,674.32$15,906$926.08+$1.63MQGLHF
4$3,297,789$1,531,361.90$19,071$1,382.55+$3.28MQGLHF
5$4,958,104$1,429,469.96$23,302$2,095.81+$4.93MQGLHF
6$6,309,449$1,004,278.25$29,150$3,237.93+$6.28MQGLHF
7$7,348,306$597,194.95$37,536$5,121.41+$7.31MQGLHF
8$8,187,698$325,011.04$50,079$8,338.38+$8.14MQGLHF
9$8,930,060$169,222.83$69,753$14,065.80+$8.86MQGLHF
10$9,641,410$86,245.75$102,337$24,771.77+$9.54MQGLHF

QGLHF vs ABBV: Complete Analysis 2026

QGLHFStock

Qingling Motors Co., Ltd., together with its subsidiaries, produces and sells Isuzu trucks in the People's Republic of China. The company offers light, medium, and heavy-duty trucks; pick-up trucks; and chassis, automobile parts, engines, accessories, and others. It is also involved in the production of moulds for manufacturing automobile parts; and automobile retailing and after-sales service business. In addition, it exports its products. The company was founded in 1946 and is based in Central, Hong Kong. Qingling Motors Co., Ltd. is a subsidiary of Qingling Motors (Group) Company Limited.

Full QGLHF Calculator →

ABBVHealthcare

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Full ABBV Calculator →
📬

Get this QGLHF vs ABBV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QGLHF vs SCHDQGLHF vs JEPIQGLHF vs OQGLHF vs KOQGLHF vs MAINQGLHF vs JNJQGLHF vs MRKQGLHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.